sFlt-1 blocks the receptor-binding domains of vascular endothelial growth factor (VEGF) and placental growth factor (PGF), causing endothelial dysfunction36 and when widespread culminates into the hypertension, proteinuria and multisystem damage characteristic of antepartum PE37. This evidence concerns the gene VEGFA and hypertensive disorder.